The company forecasts $5 billion in COVID vaccine ... our list price—when we have our updated vaccines—to be in the range of $110 to $130," Garay said. In March, Moderna CEO Stéphane Bancel ...

The logistics involved will become more costly and complex than when Moderna was selling directly to national governments. But the company plans on increasing the price of its vaccine to as much ...

Pfizer and Moderna say their work on their blockbuster Covid vaccines is ... length of the mRNA strand in the vaccine, according to Burton. The shot could increase the number of vaccine ...

Moderna (NASDAQ ... Decline 20% In December? Vaccine specialist Novavax (NASDAQ: NVAX) - which is seen as a key player in the Covid-19 vaccine space - saw its stock price decline by about 20% ...

Novavax Inc's head of research and development on Monday said an updated COVID-19 vaccine the company is already producing is ...

Moderna CEO Stéphane Bancel explains how technology from a promising new melanoma vaccine with Merck could help treat and defeat other diseases like lung, prostate and breast cancers. COVID-19 ...

Protesters gathered Wednesday afternoon outside the Beacon Hill home of the Moderna CEO Stéphane Bancel, calling on the company to make the technology behind its COVID-19 vaccine ... capacity to ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

What is the risk of stroke after the COVID-19 vaccine? Researchers have continued to study stroke risk after COVID-19 vaccination. So far, many have found that there’s no increase in the ...

Wait, why are y'all pissed at this dude? Who's buying the vaccines? Oh right, the government. Well who's funding the government? Oh right, we are (sort of; see next question). Who's adding to the ...

With an underused COVID-19 as vaccine its lone product, Novavax said earlier this year it may not be able to stay solvent and ...